Logo image of CXE

MFS HIGH INCOME MUNICIPAL TR (CXE) Stock Price, Quote, News and Overview

NYSE:CXE - New York Stock Exchange, Inc. - US59318D1046 - Currency: USD

3.585  +0 (+0.14%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CXE. CXE was compared to 0 industry peers in the Unkown industry. CXE may be in some trouble as it scores bad on both profitability and health. CXE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CXE was profitable.
CXE had a positive operating cash flow in the past year.
Of the past 5 years CXE 4 years were profitable.
CXE had a positive operating cash flow in each of the past 5 years.
CXE Yearly Net Income VS EBIT VS OCF VS FCFCXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA 1.17%
ROE 1.94%
ROIC 1.86%
ROA(3y)-3.38%
ROA(5y)-0.77%
ROE(3y)-5.74%
ROE(5y)-1.46%
ROIC(3y)2.05%
ROIC(5y)2.17%
CXE Yearly ROA, ROE, ROICCXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

CXE's Profit Margin has declined in the last couple of years.
CXE's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of CXE has declined.
Industry RankSector Rank
OM 47.73%
PM (TTM) 23.94%
GM 46.96%
OM growth 3Y-10.44%
OM growth 5Y-6.43%
PM growth 3Y50.1%
PM growth 5Y-5.85%
GM growth 3Y-10.82%
GM growth 5Y-6.75%
CXE Yearly Profit, Operating, Gross MarginsCXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

CXE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CXE remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CXE has an improved debt to assets ratio.
CXE Yearly Shares OutstandingCXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CXE Yearly Total Debt VS Total AssetsCXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

CXE has an Altman-Z score of 0.74. This is a bad value and indicates that CXE is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of CXE is 8.15, which is on the high side as it means it would take CXE, 8.15 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.65 indicates that CXE is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 8.15
Altman-Z 0.74
ROIC/WACCN/A
WACCN/A
CXE Yearly LT Debt VS Equity VS FCFCXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.3 Liquidity

CXE has a Current Ratio of 0.36. This is a bad value and indicates that CXE is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.36 indicates that CXE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
CXE Yearly Current Assets VS Current LiabilitesCXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 107.16% over the past year.
Measured over the past years, CXE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.09% on average per year.
The Revenue has been growing slightly by 5.73% in the past year.
CXE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.81% yearly.
EPS 1Y (TTM)107.16%
EPS 3Y45.23%
EPS 5Y-11.09%
EPS Q2Q%104.31%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y-3.2%
Revenue growth 5Y-5.81%
Sales Q2Q%3.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CXE Yearly Revenue VS EstimatesCXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.81, the valuation of CXE can be described as expensive.
CXE is valuated expensively when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.81
Fwd PE N/A
CXE Price Earnings VS Forward Price EarningsCXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 11.31
EV/EBITDA N/A
CXE Per share dataCXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.97%, CXE is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.44, CXE pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.97%

5.2 History

The dividend of CXE decreases each year by -11.23%.
CXE has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of CXE decreased recently.
Dividend Growth(5Y)-11.23%
Div Incr Years1
Div Non Decr Years1
CXE Yearly Dividends per shareCXE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

CXE pays out 203.85% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CXE has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP203.85%
EPS Next 2YN/A
EPS Next 3YN/A
CXE Yearly Income VS Free CF VS DividendCXE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M
CXE Dividend Payout.CXE Dividend Payout, showing the Payout Ratio.CXE Dividend Payout.PayoutRetained Earnings

More info and screens

MFS HIGH INCOME MUNICIPAL TR

NYSE:CXE (5/2/2025, 8:04:00 PM)

3.585

+0 (+0.14%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners41.23%
Inst Owner Change0.02%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap113.04M
Analysts0
Price TargetN/A
Short Float %0.18%
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield 4.97%
Yearly Dividend0.16
Dividend Growth(5Y)-11.23%
DP203.85%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.016)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 44.81
Fwd PE N/A
P/S 11.04
P/FCF 11.31
P/OCF 11.31
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)0.08
EY2.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.32
FCFY8.85%
OCF(TTM)0.32
OCFY8.85%
SpS0.32
BVpS4
TBVpS4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.17%
ROE 1.94%
ROCE 2.35%
ROIC 1.86%
ROICexc 1.86%
ROICexgc 1.86%
OM 47.73%
PM (TTM) 23.94%
GM 46.96%
FCFM 97.64%
ROA(3y)-3.38%
ROA(5y)-0.77%
ROE(3y)-5.74%
ROE(5y)-1.46%
ROIC(3y)2.05%
ROIC(5y)2.17%
ROICexc(3y)2.05%
ROICexc(5y)2.17%
ROICexgc(3y)2.05%
ROICexgc(5y)2.17%
ROCE(3y)2.6%
ROCE(5y)2.74%
ROICexcg growth 3Y-6.33%
ROICexcg growth 5Y-7.75%
ROICexc growth 3Y-6.33%
ROICexc growth 5Y-7.75%
OM growth 3Y-10.44%
OM growth 5Y-6.43%
PM growth 3Y50.1%
PM growth 5Y-5.85%
GM growth 3Y-10.82%
GM growth 5Y-6.75%
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 8.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 407.82%
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z 0.74
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.16%
EPS 3Y45.23%
EPS 5Y-11.09%
EPS Q2Q%104.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y-3.2%
Revenue growth 5Y-5.81%
Sales Q2Q%3.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.04%
EBIT growth 3Y-13.31%
EBIT growth 5Y-11.86%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.49%
FCF growth 3Y9.48%
FCF growth 5Y1.99%
OCF growth 1Y-42.49%
OCF growth 3Y9.48%
OCF growth 5Y1.99%